Susan C. Charman

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Safety of inhaled levofloxacin in people with cystic fibrosis: Data from UK and German Registries.

Safety of inhaled levofloxacin in people with cystic fibrosis: Data from UK and German Registries.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: December 02, 2025

Global Collaboration in Cystic Fibrosis: Lessons From the COVID-19 Pandemic for Low- and Middle-Income Countries.

Global Collaboration in Cystic Fibrosis: Lessons From the COVID-19 Pandemic for Low- and Middle-Income Countries.

Journal: Pediatric pulmonology

Published: August 18, 2025

Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population.

Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: July 31, 2025

Yoga Outcomes Get Assessed in Cystic Fibrosis (YOGA-CF): protocol of a multicentre interventional randomised controlled clinical trial-investigating effects of a 12-week yoga intervention for adults with cystic fibrosis.

Yoga Outcomes Get Assessed in Cystic Fibrosis (YOGA-CF): protocol of a multicentre interventional randomised controlled clinical trial-investigating effects of a 12-week yoga intervention for adults with cystic fibrosis.

Journal: BMJ open respiratory research

Published: April 18, 2025

Effects of azithromycin in young adults with cystic fibrosis: a protocol for emulating a published randomised controlled trial using registry data.

Effects of azithromycin in young adults with cystic fibrosis: a protocol for emulating a published randomised controlled trial using registry data.

Journal: BMJ open

Published: March 25, 2025

"Mind the gap"- will we ever see equal median predicted survival for males and females in cystic fibrosis?

"Mind the gap"- will we ever see equal median predicted survival for males and females in cystic fibrosis?

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: March 03, 2025

LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis.

LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: October 10, 2024

Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study.

Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: April 25, 2024

Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review.

Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review.

Journal: Therapeutic advances in respiratory disease

Published: September 06, 2022

Who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies.

Who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies.

Journal: Respiratory medicine

Published: November 03, 2021

Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data.

Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data.

Journal: Thorax

Published: January 05, 2021

Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry.

Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: May 16, 2020

Showing 1-12 of 51

Last Updated: 09/26/2026